Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$1.54M Sell
46,749
-422
-0.9% -$13.4K 0.36% 51
2014
Q4
$1.39M Buy
47,171
+3,637
+8% +$104K 0.3% 55
2014
Q3
$1.22M Sell
43,534
-791
-2% -$22.2K 0.27% 55
2014
Q2
$1.25M Buy
44,325
+782
+2% +$22.3K 0.28% 52
2014
Q1
$1.33M Sell
43,543
-630
-1% -$18.8K 0.3% 48
2013
Q4
$1.28M Sell
44,173
-582
-1% -$16.9K 0.33% 47
2013
Q3
$1.22M Buy
44,755
+1,172
+3% +$31.9K 0.35% 47
2013
Q2
$1.16M Buy
+43,583
New +$1.2M 0.35% 45

Other funds holding PFE

Bank of Kentucky's PFE Position: Q1 2015 in Review

Bank of Kentucky reduced its Pfizer (PFE) stake by 0.89% in Q1 2015, selling an estimated $13.4K and leaving 46,749 shares worth $1.54M. The position accounts for 0.36% of the portfolio, ranked #51.

Bank of Kentucky first reported a position in PFE in Q2 2013 and has held it in 8 quarters since. 1,876 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

  • Bank of Kentucky held 46,749 shares of Pfizer worth $1.54M as of Q1 2015.
  • Bank of Kentucky sold 422 Pfizer shares in Q1 2015, an estimated $13.4K.
  • Pfizer made up 0.36% of Bank of Kentucky's portfolio in Q1 2015, its #51 holding.
  • Bank of Kentucky first reported a position in Pfizer in Q2 2013 and has held it in 8 quarters since.
  • 1,876 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Bank of Kentucky's 13F filing for Q1 2015, filed 28 Apr 2015.